A panelist discusses how their institution is proactively adapting their formulary review processes and infrastructure to handle the growing biosimilar pipeline, while anticipating increased competition will drive strategic shifts in contracting and necessitate more flexible approaches to formulary management in the coming years.
Video content above is prompted by the following:
Get the latest industry news, event updates, and more from Managed healthcare Executive.